舒泰神还是各种不靠谱啊
IFRX自己公布的那个数据结果,一眼看上去就跟做梦一样!
但最蹊跷的是,最后一组数据,安慰剂组(理论上的空白对照组),有效47.1%?!
意思是通过16周的对照试验,发现有47.1%的人,天天吃安慰剂(理解成喝白水/打葡萄糖吧),结果自愈么?
IFRX的人估计也是一脸懵逼!没有特效药的适应症,做出47.1%的安慰剂有效,那结论只能说是对照数据不明显,没法说药物无效啊!看看IFRX的报告原文咋说的:
“IFX-1 did not demonstrate a statistical significant dose dependent effect on Hidradenitis Suppurativa Clinical Response (HiSCR) rate at week 16 as primary endpoint.”
“IFX-1在第16周作为主要终点时,对化脓性汗腺炎的临床反应率(HiSCR)没有明显的剂量依赖效应”
“Othmar Zenker, Chief Medical Officer of InflaRx, said: “We are disappointed that we were not able to demonstrate a significant signal on dose response for the treatment with IFX-1. While we are still analyzing additional data, we note that the trial demonstrated an unusually high placebo HiSCR rate at week 16”.”
“InflaRx的首席医疗官Othmar Zenker说:“我们很失望,我们不能证明IFX-1治疗的剂量反应有显著的信号。虽然我们还在分析其他数据,但我们注意到,该试验显示,安慰剂HiSCR率在第16周异常高。”
他们自己也觉得安慰剂组数据异常的高,我估计是安慰剂组的设置或者参数模型出问题了,这个16周数据太反直觉,继续观望,等待IFRX后面给出更多的数据分析结果吧,还有就是28周的数据结果。
期待剧情反转!